Evidence map›Paper›PMID 40861548›Full record

ArticleCureus2025

Prolonged Effects of COVID-19-Related Behavioral Restrictions on Neonatal Bone Metabolism: A Retrospective Study.

Tatenobu Goto, Ayako Uemura, Hiroto Maeda, Masashi Tanikawa, Mari Mizutani, Yuto Kondo, Megumi Suyama, Tomoki Goto, Kanemasa Maki, Katsumi Ushijima

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tatenobu GotoDivision of Pediatrics, Yokkaichi Municipal Hospital, Yokkaichi, JPN.
Ayako UemuraDivision of Pediatrics, Yokkaichi Municipal Hospital, Yokkaichi, JPN.
Hiroto MaedaDivision of Pediatrics, Yokkaichi Municipal Hospital, Yokkaichi, JPN.
Masashi TanikawaDivision of Pediatrics, Yokkaichi Municipal Hospital, Yokkaichi, JPN.
Mari MizutaniDivision of Pediatrics, Yokkaichi Municipal Hospital, Yokkaichi, JPN.
Yuto KondoDivision of Pediatrics, Yokkaichi Municipal Hospital, Yokkaichi, JPN.
Megumi SuyamaDivision of Pediatrics, Yokkaichi Municipal Hospital, Yokkaichi, JPN.
Tomoki GotoDivision of Pediatrics, Yokkaichi Municipal Hospital, Yokkaichi, JPN.
Kanemasa MakiDivision of Pediatrics, Yokkaichi Municipal Hospital, Yokkaichi, JPN.
Katsumi UshijimaDivision of Pediatrics, Yokkaichi Municipal Hospital, Yokkaichi, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe COVID-19 pandemic introduced significant lifestyle changes, such as reduced outdoor activities, social distancing, and other public health measures. These changes may have affected maternal health and neonatal biochemical parameters linked to bone metabolism. This retrospective study aimed to evaluate the impact of pandemic-related behavioral restrictions on neonatal biochemical markers, including calcium, phosphate, magnesium, intact parathyroid hormone (iPTH), and alkaline phosphatase (ALP), measured on the first day of life across three distinct time periods (pre-COVID-19, COVID-19 pandemic, and post-COVID-19). MATERIALS AND

methodsThis retrospective cohort study included 964 neonates admitted to a Japanese neonatal intensive care unit between 2018 and 2024. Neonates were categorized into three groups: pre-COVID-19 (2018-2020), COVID-19 pandemic (2020-2022), and post-COVID-19 (2022-2024) periods. Serum biochemical parameters were measured on the first day of life and compared statistically among the groups.

resultsThere were no significant differences in gestational age and birth weight among the three groups. Serum phosphate levels demonstrated a significant, stepwise increase across the periods (pre-COVID-19: 5.4 (4.8-5.9) mg/dL, COVID-19 pandemic: 5.6 (5.0-6.1) mg/dL, post-COVID-19: 5.7 (5.2-6.4) mg/dL; p<0.01). Magnesium levels significantly decreased in the post-COVID-19 period (pre-COVID-19: 2.05 (1.9-2.3) mg/dL, post-COVID-19: 1.90 (1.8-2.2) mg/dL; p<0.01). No significant changes were observed in calcium, iPTH, or ALP levels.

conclusionsPandemic-related lifestyle changes caused significant and persistent alterations in neonatal phosphate and magnesium metabolism, necessitating continuous monitoring and preventive strategies to address long-term health impacts.

Indexed as

covid-19 pandemicmaternal behavioral changematernal-infant interactionneonatal bone metabolismnewborn healthnutritional deficiencypandemic impactparathyroid hormone (pth)postnatal developmentvitamin d deficiency

Identifiers

PMID40861548
PMCPMC12373416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.